{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:16Z","timestamp":1761129316022,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research (IN)","doi-asserted-by":"publisher","award":["27(0236)\/10\/EMR-II"],"award-info":[{"award-number":["27(0236)\/10\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00705-016-2760-8","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T04:17:03Z","timestamp":1453436223000},"page":"1101-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy"],"prefix":"10.1007","volume":"161","author":[{"given":"Mohammad","family":"Misbah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mudassar","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalin","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"2760_CR1","unstructured":"World Health Organization (WHO)\u2013\u00a0HIV\/AIDS Fact Sheet, Updated November (2014). http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/"},{"key":"2760_CR2","unstructured":"National AIDS Control Organisation (NACO), Ministry of health and Family Welfare (2014) Annual report. http:\/\/www.naco.gov.in\/upload\/2014%20mslns\/NACO_English%202013-14.pdf"},{"key":"2760_CR3","author":"S Sinha","year":"2012","unstructured":"Sinha S, Ahmad H, Shekhar RC, Kumar N, Dar L, Samantaray JC, Sharma SK, Bhargava A, Pandey RM, Mitsuyasu RL, Fahey JL (2012) Prevalence of HIV drug resistance mutations in HIV type 1 isolates in antiretroviral therapy na\u00efve population from northern India. AIDS Res Treat. doi: 10.1155\/2012\/905823","journal-title":"AIDS Res Treat"},{"key":"2760_CR4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","volume":"352","author":"A Mocroft","year":"1998","unstructured":"Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d\u2019Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352:1725\u20131730. doi: 10.1016\/S0140-6736(98)03201-2","journal-title":"Lancet"},{"key":"2760_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002030-200001280-00016","volume":"14","author":"MG Law","year":"2000","unstructured":"Law MG, Li Y, McDonald AM, Cooper DA, Kaldor JM (2000) Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection. AIDS 14:197\u2013201","journal-title":"AIDS"},{"key":"2760_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.283.2.250","volume":"283","author":"M Markowitz","year":"2000","unstructured":"Markowitz M (2000) Resistance, fitness, adherence and potency: mapping the paths to virologic failure. JAMA 283:250\u2013251. doi: 10.1001\/jama.283.2.250","journal-title":"JAMA"},{"key":"2760_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0005361","volume":"4","author":"DE Bennett","year":"2009","unstructured":"Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW (2009) Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 4:1\u20138. doi: 10.1371\/journal.pone.0090710","journal-title":"PLoS One"},{"key":"2760_CR8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","volume":"18","author":"DD Richman","year":"2004","unstructured":"Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA (2004) The prevalence of antiretroviral drug resistance in the United States. AIDS 18:1393\u20131401. doi: 10.1097\/01.aids.0000131310.52526.c7","journal-title":"AIDS"},{"key":"2760_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","volume":"347","author":"SJ Little","year":"2002","unstructured":"Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347:385\u2013394. doi: 10.1056\/NEJMoa013552","journal-title":"N Engl J Med"},{"key":"2760_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/03008870310009597","volume":"106","author":"E Girardi","year":"2003","unstructured":"Girardi E (2003) Epidemiology aspects of transmitted HIV drug resistance. Scand J Dis Suppl 106:17\u201320","journal-title":"Scand J Dis Suppl"},{"key":"2760_CR11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1371\/journal.pmed.0020112","volume":"2","author":"R Kantor","year":"2005","unstructured":"Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares MA, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber JN, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Shafer RW (2005) Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med 2:325\u2013337. doi: 10.1371\/journal.pmed.0020112","journal-title":"PLoS Med"},{"key":"2760_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0255-0857.53205","volume":"27","author":"AJ Kandathil","year":"2009","unstructured":"Kandathil AJ, Kannangai R, Varghese R, Pulimood SA, Rupali A, Sridharan G, Grant P, Pillay D, Abraham OC (2009) Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Indian J Med Microbiol 27:231\u2013236. doi: 10.4103\/0255-0857.53205","journal-title":"Indian J Med Microbiol"},{"key":"2760_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1545109711421217","volume":"11","author":"S Saini","year":"2012","unstructured":"Saini S, Bhalla P, Gautam H, Baveja UK, Pasha ST, Dewan R (2012) Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic) 11:203\u2013209. doi: 10.1177\/1545109711421217","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"2760_CR14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1089\/aid.2008.0079","volume":"24","author":"M Lall","year":"2008","unstructured":"Lall M, Gupta RM, Sen S, Kapila K, Tripathy SP, Paranjape RS (2008) Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India. AIDS Res Hum Retroviruses 24:987\u2013990. doi: 10.1089\/aid.2008.0079","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR15","unstructured":"World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents, recommendations for a public health approach. 2010 revision. http:\/\/apps.who.int\/iris\/bitstream\/10665\/44379\/1\/9789241599764_eng.pdf"},{"key":"2760_CR16","unstructured":"National AIDS Control Organisation (NACO), Ministry of health and Family Welfare (2008) National guidelines on second line ART for adults and adolescents"},{"key":"2760_CR17","unstructured":"Stanford Drug Resistance Database. http:\/\/hivdb.stanford.edu"},{"key":"2760_CR18","unstructured":"REGA algorithm version 8.02. http:\/\/www.kuleuven.ac.be\/rega\/cev\/links or http:\/\/www.rega.kuleuven.be\/cev\/"},{"key":"2760_CR19","first-page":"6","volume":"21","author":"VA Johnson","year":"2013","unstructured":"Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD (2013) Update of the drug resistance mutations in HIV-1. Top Antivir Med 21:6\u201314","journal-title":"Top Antivir Med"},{"key":"2760_CR20","unstructured":"French ANRS (National Agency for AIDS Research) AC11 resistance group (2012) HIV-1 genotypic drug resistance interpretations algorithms. http:\/\/www.hivfrenchresistance.org\/hivfrenchres.pdf . Accessed September, 2012"},{"key":"2760_CR21","unstructured":"REGA HIV-1 subtyping tool-version 2.0. http:\/\/dbpartners.stanford.edu\/RegaSubtyping . Accessed 20 Aug 2012"},{"key":"2760_CR22","unstructured":"Felsenstein J (1993) PHYLIP package (v3.69). http:\/\/evolution.genetics.washington.edu\/phylip\/getme.html . Accessed 07 July 2012"},{"key":"2760_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1086\/588675","volume":"198","author":"VD Lima","year":"2008","unstructured":"Lima VD, Gill VS, Yip B, Hogg RS, Montaner JS, Harrigan PR (2008) Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy. J Infect Dis 198:51\u201358. doi: 10.1086\/588675","journal-title":"J Infect Dis"},{"key":"2760_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/595298","volume":"199","author":"C Danel","year":"2009","unstructured":"Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X (2009) Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. J Infect Dis 199:66\u201376. doi: 10.1086\/595298","journal-title":"J Infect Dis"},{"key":"2760_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1746-1596-7-138","volume":"7","author":"A Elmi Abar","year":"2012","unstructured":"Elmi Abar A, Jlizi A, Darar HY, Kacem MA, Slim A (2012) HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naive and first-line treatment failures in Djiboutian patients. Diagn Pathol 7:138. doi: 10.1186\/1746-1596-7-138","journal-title":"Diagn Pathol"},{"key":"2760_CR26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1089\/aid.2007.0090","volume":"23","author":"S Sen","year":"2007","unstructured":"Sen S, Tripathy SP, Patil AA, Chimanpure VM, Paranjape RS (2007) High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India. AIDS Res Hum Retroviruses 23:1303\u20131308. doi: 10.1089\/aid.2007.0090","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.283.2.205","volume":"283","author":"D Descamps","year":"2000","unstructured":"Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F, Brun-V\u00e9zinet F (2000) Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team. JAMA 283:205\u2013211. doi: 10.1001\/jama.283.2.205","journal-title":"JAMA"},{"key":"2760_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.283.2.229","volume":"283","author":"DV Havlir","year":"2000","unstructured":"Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD (2000) Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA 283:229\u2013234. doi: 10.1001\/jama.283.2.229","journal-title":"JAMA"},{"key":"2760_CR29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/viro.1994.1130","volume":"199","author":"J Ji","year":"1994","unstructured":"Ji J, Loeb LA (1994) Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology 199:323-330. Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology 199:323\u2013330. doi: 10.1006\/viro.1994.1130","journal-title":"Virology"},{"key":"2760_CR30","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JVI.71.4.3346-3350.1997","volume":"71","author":"W Keulen","year":"1997","unstructured":"Keulen W, Back NK, van Wijk A, Boucher CA, Berkhout B (1997) Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse\u00a0transcriptase. J Virol 71:3346\u20133350","journal-title":"J Virol"},{"key":"2760_CR31","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1089\/aid.2004.20.1032","volume":"20","author":"A Deshpande","year":"2004","unstructured":"Deshpande A, Recordon-Pinson P, Deshmukh R, Faure M, Jauvin V, Garrigue I, Lafon ME, Fleury HJ (2004) Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. AIDS Res Hum Retroviruses 20:1032\u20131035. doi: 10.1089\/aid.2004.20.1032","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00705-013-1889-y","volume":"159","author":"M Azam","year":"2014","unstructured":"Azam M, Malik A, Rizvi M, Rai A (2014) Trends of drug-resistance-associated mutations in the reverse transcriptase gene of HIV type 1 isolates from North India. Arch Virol 159:719\u2013725. doi: 10.1007\/s00705-013-1889-y","journal-title":"Arch Virol"},{"key":"2760_CR33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3851\/IMP1411","volume":"14","author":"M Vidya","year":"2009","unstructured":"Vidya M, Saravanan S, Uma S, Kumarasamy N, Sunil SS, Kantor R, Katzenstein D, Ramratnam B, Mayer HK, Suniti S, Balakrishnan P (2009) Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India. Antivir Ther 14:1005\u20131009. doi: 10.3851\/IMP1411","journal-title":"Antivir Ther"},{"key":"2760_CR34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/135965350501000705","volume":"10","author":"A Cozzi-Lepri","year":"2005","unstructured":"Cozzi-Lepri A, Ruiz L, Loveday C, Phillips AN, Clotet B, Reiss P, Ledergerber B, Holkmann C, Staszewski S, Lundgren JD (2005) Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy. Antivir Ther 10:791\u2013802","journal-title":"Antivir Ther"},{"key":"2760_CR35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1086\/522231","volume":"196","author":"A Luca De","year":"2007","unstructured":"De Luca A, Giambenedetto SD, Trotta MP, Colafigli M, Prosperi M, Ruiz L, Baxter J, Clevenbergh P, Cauda R, Perno CF, Antinori A (2007) Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine. J Infect Dis 196:1645\u20131653. doi: 10.1086\/522231","journal-title":"J Infect Dis"},{"key":"2760_CR36","author":"S Vallabhaneni","year":"2013","unstructured":"Vallabhaneni S, Chandy S, Heylen E, Ekstrand ML (2013) Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India. J Int AIDS Soc. doi: 10.7448\/IAS.16.1.18449","journal-title":"J Int AIDS Soc"},{"key":"2760_CR37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1258\/ijsa.2008.008403","volume":"20","author":"AJ Kandathil","year":"2009","unstructured":"Kandathil AJ, Kannangai R, Abraham OC, Rupali P, Pulimood SA, Verghese VP, Grant P, Pillay D, Sridharan G (2009) The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India. Int J STD AIDS 20:522\u2013526. doi: 10.1258\/ijsa.2008.008403","journal-title":"Int J STD AIDS"},{"key":"2760_CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/aid.2007.0156","volume":"24","author":"SK Arora","year":"2008","unstructured":"Arora SK, Gupta S, Toor JS, Singla A (2008) Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India. AIDS Res Hum Retroviruses 24:125\u2013130. doi: 10.1089\/aid.2007.0156","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00126334-200108010-00008","volume":"27","author":"NS Shulman","year":"2001","unstructured":"Shulman NS, Machekano RA, Shafer RW, Winters MA, Zolopa AR, Liou SH, Hughes M, Katzenstein DA (2001) Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. J Acquir Immune Defic Syndr 27:377\u2013380","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2760_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002030-200001280-00002","volume":"14","author":"E Coakley","year":"2000","unstructured":"Coakley E, Gillis J, Hammer S (2000) Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. AIDS 14:9\u201316","journal-title":"AIDS"},{"key":"2760_CR41","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.44.8.2109-2117.2000","volume":"44","author":"K Vaerenbergh Van","year":"2000","unstructured":"Van Vaerenbergh K, Van Laethem K, Albert J, Boucher CA, Clotet B, Floridia M, Gerstoft J, Hejdeman B, Nielsen C, Pannecouque C, Perrin L, Pirillo MF, Ruiz L, Schmit JC, Schneider F, Schoolmeester A, Schuurman R, Stellbrink HJ, Stuyver L, Van Lunzen J, Van Remoortel B, Van Wijngaerden E, Vella S, Witvrouw M, Yerly S, De Clercq E, Destmyer J, Vandamme AM (2000) Prevalence and characteristics of multinucleoside-resistant HIV-1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother 44:2109\u20132117. doi: 10.1128\/AAC.44.8.2109-2117.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2760_CR42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/aid.2006.0183","volume":"23","author":"A Deshpande","year":"2007","unstructured":"Deshpande A, Jauvin V, Magnin N, Pinson P, Faure M, Masquelier B, Aurillac-Lavignolle V, Fleury HJ (2007) Resistance mutations in\u00a0subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to AR. AIDS Res Hum Retroviruses 23:335\u2013340. doi: 10.1089\/aid.2006.0183","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR43","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/315329","volume":"181","author":"GJ Hanna","year":"2000","unstructured":"Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Brown AJ, Savara AV, Hazelwood JD, D\u2019Aquila RT (2000) Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine. J. Infect. Dis 181:904\u2013911. doi: 10.1086\/315329","journal-title":"J. Infect. Dis"},{"key":"2760_CR44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/AAC.01335-09","volume":"54","author":"A Maiga","year":"2010","unstructured":"Maiga A, Descamps D, Morand-Joubert L, Malet I, Derache A, Cisse M, Koita V, Akonde A, Diarra B, Wirden M, Tounkara A, Verlinden Y, Katlama C, Costagliola D, Masquelier B, Calvez V, Marcelin AG (2010) Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes. Antimicrob Agents Chemother 54:728\u2013733. doi: 10.1128\/AAC.01335-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2760_CR45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00126334-200009010-00015","volume":"25","author":"O Gallego","year":"2000","unstructured":"Gallego O, Briones C, Corral A, Soriano V (2000) Prevalence of novel lamivudine-resistant genotypes (E44D\/A, V118I) in naive and pre-treated HIV-infected individuals. J Acquir Immune Defic Syndr 25:95\u201396","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2760_CR46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.44.3.568-573.2000","volume":"44","author":"K Hertogs","year":"2000","unstructured":"Hertogs K, Bloor S, De Vroey V, van Den Eynde C, Dehertogh P, van Cauwenberge A, Sturmer M, Alcorn T, Wegner S, van Houtte M, Miller V, Larder BA (2000) A novel HIV-1 RT mutational pattern confers phenotypic lamivudine resistance in the absence of mutation M184V. Antimicrob Agents Chemother 44:568\u2013573. doi: 10.1128\/AAC.44.3.568-573.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2760_CR47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/aid.2010.0032","volume":"26","author":"DN Chaturbhuj","year":"2010","unstructured":"Chaturbhuj DN, Hingankar NK, Srikantiah P, Garg R, Kabra S, Deshmukh PS, Jadhav SD, Thorat SR, Datkar SR, Mehta P, Ingole N, Mathur M, Ramachandran A, Haldar P, Reddy DC, Bachani D, Rao S, Tripathy SP, Paranjape RS (2010) Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. AIDS Res Hum Retroviruses 26:927\u2013932. doi: 10.1089\/aid.2010.0032","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR48","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/088922200308819","volume":"16","author":"R Downing","year":"2000","unstructured":"Downing R, Pieniazek D, Hu DJ, Biryahwaho B, Fridlund C, Rayfield MA, Sempala SD, Lal RB (2000) Genetic characterization and phylogenetic analysis of HIV-1 subtype C from Uganda. AIDS Res Hum Retroviruses 16:815\u2013819. doi: 10.1089\/088922200308819","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2760_CR49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1089\/aid.2006.22.1206","volume":"22","author":"M Kumar","year":"2006","unstructured":"Kumar M, Jain SK, Pasha ST, Chattopadhya D, Lal S, Rai A (2006) Genomic diversity in the regulatory nef gene sequences in Indian isolates of HIV type 1: emergence of a distinct subclade and predicted implications. AIDS Res Hum Retroviruses 22:1206\u20131219. doi: 10.1089\/aid.2006.22.1206","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-016-2760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2760-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T04:34:11Z","timestamp":1654144451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-016-2760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-2760-8","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}